MEX3A and gastric cancer: In particular, the protein dysregulation of MEX3A was significantly associated with a variety of human malignant tumors, such as in gastric cancer, colorectal cancer, bladder cancer, and pancreatic ductal adenocarcinoma [14, 17, 23–25].